这些发现提示，针对不同B细胞亚群的联合治疗可能是未来方向。 在类似疾病中，慢性移植物抗宿主病（cGvHD）皮肤可见CD19 + 细胞增加，肺组织有B220 + 细胞聚集和Ig沉积。局限型硬皮病（硬斑病）皮肤显示CD20 + 细胞浸润和MZB1 + 浆细胞聚集，与SSc炎症亚型相似。

为解决 CAR-T 细胞疗法存在的诸多问题，如成本高、毒性大等，浙江大学医学院附属第二医院等机构的研究人员开展了 4-1BB 共刺激 CD19 特异性 CAR-NK 细胞（CD19-BBz CAR-NK）治疗难治 / 复发大 B 细胞淋巴瘤的 1 期临床试验。结果显示该疗法安全可行，能诱导持久缓解 ...

Clinical-grade CAR-T cell manufacturing was performed in a closed system using a second-generation CD19 vector with 41BB costimulatory domain. Quality control was assessed at different points in the ...

A third CD19-targeted CAR-T, Bristol-Myers Squibb's Breyanzi (lisocabtagene maraleucel), is on the market for other blood cancers, but not ALL. Aucatzyl will now have to carve out market share ...

“CLN-978 is the only CD19-targeting T cell engager advancing a global regulatory development plan that includes a US FDA-cleared IND. Delivering the potency of T cell redirecting therapy with the ...

At the forefront of discussions at ACR 2024 was the success of autologous CD19-directed CAR-T cell therapies in addressing B cell-mediated autoimmune diseases such as lupus and rheumatoid arthritis.

But, if you’re bringing someone not that big on beer, they’re also featuring a traditional cocktail menu with an old fashioned (B300), Moscow to BKK Mule (B220), salted plum highball (B240), and other ...

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development. La Merie Publishing offers an e-mail notification service about the release of new products ...